These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19142126)

  • 1. Effect of donepezil on tardive dyskinesia.
    Ogunmefun A; Hasnain M; Alam A; Osuala T; Regenold WT
    J Clin Psychopharmacol; 2009 Feb; 29(1):102-4. PubMed ID: 19142126
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of tardive dyskinesia with donepezil.
    Caroff SN; Campbell EC; Havey JC; Sullivan KA; Katz IR; Mann SC
    J Clin Psychiatry; 2001 Feb; 62(2):128-9. PubMed ID: 11247101
    [No Abstract]   [Full Text] [Related]  

  • 3. Donepezil and tardive dyskinesia.
    Schopick D
    J Am Acad Child Adolesc Psychiatry; 2005 Feb; 44(2):112. PubMed ID: 15689723
    [No Abstract]   [Full Text] [Related]  

  • 4. Beneficial effect of donepezil in the treatment of elderly patients with tardive movement disorders.
    Bergman J; Dwolatzky T; Brettholz I; Lerner V
    J Clin Psychiatry; 2005 Jan; 66(1):107-10. PubMed ID: 15669896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching from donepezil to galantamine: a double-blind study of two wash-out periods.
    Wilkinson DG; Howe I
    Int J Geriatr Psychiatry; 2005 May; 20(5):489-91. PubMed ID: 15852437
    [No Abstract]   [Full Text] [Related]  

  • 6. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
    Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
    Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of levodopa-induced dyskinesias with donepezil.
    Caroff SN; Martine R; Kleiner-Fisman G; Eisa M; Lorry A; Gallop R; Stern MB; Duda JE
    Parkinsonism Relat Disord; 2006 May; 12(4):261-3. PubMed ID: 16364675
    [No Abstract]   [Full Text] [Related]  

  • 8. Donepezil minimally effective for patients with vascular dementia.
    Johnson KD
    J Fam Pract; 2004 Mar; 53(3):181-2. PubMed ID: 15000918
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of tardive dyskinesia with donepezil: a pilot study.
    Caroff SN; Campbell EC; Havey J; Sullivan KA; Mann SC; Gallop R
    J Clin Psychiatry; 2001 Oct; 62(10):772-5. PubMed ID: 11816865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tardive dyskinesia: pergolid, a possible therapeutic option].
    Diehl A; Braus DF; Büchel C; Krumm B; Medori R; Gattaz WF
    Psychiatr Prax; 2003 Sep; 30(6):333-7. PubMed ID: 12970819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic-dopaminergic imbalance in Pisa syndrome.
    Villarejo A; Camacho A; García-Ramos R; Moreno T; Penas M; Juntas R; Ruiz J
    Clin Neuropharmacol; 2003; 26(3):119-21. PubMed ID: 12782913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of tardive dyskinesia with propranolol.
    Schrodt GR; Wright JH; Simpson R; Moore DP; Chase S
    J Clin Psychiatry; 1982 Aug; 43(8):328-31. PubMed ID: 6124534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donepezil in the treatment of dementia with lewy bodies.
    Beversdorf DQ; Warner JL; Davis RA; Sharma UK; Nagaraja HN; Scharre DW
    Am J Geriatr Psychiatry; 2004; 12(5):542-4. PubMed ID: 15353396
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
    Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia].
    Kocher R; Hobi V; Linder M; Studer K
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):103-9. PubMed ID: 6106283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to manage overactive bladder in elderly individuals with dementia? A combined use of donepezil, a central acetylcholinesterase inhibitor, and propiverine, a peripheral muscarine receptor antagonist.
    Sakakibara R; Ogata T; Uchiyama T; Kishi M; Ogawa E; Isaka S; Yuasa J; Yamamoto T; Ito T; Yamanishi T; Awa Y; Yamaguchi C; Takahashi O
    J Am Geriatr Soc; 2009 Aug; 57(8):1515-7. PubMed ID: 19682155
    [No Abstract]   [Full Text] [Related]  

  • 17. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
    Shriqui CL; Bradwejn J; Annable L; Jones BD
    Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donepezil for cognitive impairment in Parkinson's disease: a randomized controlled trial.
    Marder K
    Curr Neurol Neurosci Rep; 2002 Sep; 2(5):390-1. PubMed ID: 12169217
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil.
    Galvin JE; Cornblatt B; Newhouse P; Ancoli-Israel S; Wesnes K; Williamson D; Zhu Y; Sorra K; Amatniek J
    Alzheimer Dis Assoc Disord; 2008; 22(1):30-8. PubMed ID: 18317244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.